Site-specific Incorporation of Phosphoserine into Recombinant Proteins in Escherichia coli

This protocol describes the recombinant expression of proteins in containing phosphoserine (pSer) installed at positions guided by TAG codons. The strains that can be used here are engineered with a ∆ genomic knockout to produce pSer internally at high levels, so no exogenously added pSer is require...

Full description

Saved in:
Bibliographic Details
Published inBio-protocol Vol. 12; no. 21
Main Authors Zhu, Phillip, Mehl, Ryan A, Cooley, Richard B
Format Journal Article
LanguageEnglish
Published United States Bio-Protocol 05.11.2022
Bio-protocol LLC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This protocol describes the recombinant expression of proteins in containing phosphoserine (pSer) installed at positions guided by TAG codons. The strains that can be used here are engineered with a ∆ genomic knockout to produce pSer internally at high levels, so no exogenously added pSer is required, and the addition of pSer to the media will not affect expression yields. For "truncation-free" expression and improved yields with high flexibility of construct design, it is preferred to use the Release Factor-1 (RF1) deficient strain B95(DE3) ∆ ∆ ∆ , though use of the standard RF1-containing BL21(DE3) ∆ is also described. Both of these strains are serine auxotrophs and will not grow in standard minimal media. This protocol uses rich auto-induction media for streamlined and maximal production of homogeneously modified protein, yielding ~100-200 mg of single pSer-containing sfGFP per liter of culture. Using this genetic code expansion (GCE) approach, in which pSer is installed into proteins during translation, allows researchers to produce milligram quantities of specific phospho-proteins without requiring kinases, which can be purified for downstream in vitro studies relating to phosphorylation-dependent signaling systems, protein regulation by phosphorylation, and protein-protein interactions. Graphical abstract.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2331-8325
2331-8325
DOI:10.21769/BioProtoc.4541